Reviva Pharmaceuticals Holdings Inc (RVPH)
1.71
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.70
-0.01
(-0.58%)
After-Hours: 04:57
Reviva Pharmaceuticals Holdings Total Liabilities (Quarterly): 14.84M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.84M |
December 31, 2023 | 17.98M |
September 30, 2023 | 13.91M |
June 30, 2023 | 10.22M |
March 31, 2023 | 7.117M |
December 31, 2022 | 10.53M |
September 30, 2022 | 3.681M |
June 30, 2022 | 4.583M |
Date | Value |
---|---|
March 31, 2022 | 3.907M |
December 31, 2021 | 2.718M |
September 30, 2021 | 1.625M |
June 30, 2021 | 2.014M |
March 31, 2021 | 2.142M |
December 31, 2020 | 3.296M |
November 30, 2020 | 5.049M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.625M
Minimum
Sep 2021
17.98M
Maximum
Dec 2023
6.908M
Average
4.583M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
AbbVie Inc | 140.83B |
ABVC BioPharma Inc | 6.362M |
Sutro Biopharma Inc | 305.38M |
Flora Growth Corp | 17.22M |
Journey Medical Corp | 53.62M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.50M |
Shareholders Equity (Quarterly) | -1.346M |